Darin Lippoldt - 31 Jan 2022 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NBIX	Stock Option	Award	$0	+64,638		$0.000000	64,638	31 Jan 2022	Common Stock	64,638	$79.02	Direct	F1
transaction	NBIX	Restricted Stock Unit	Award	$0	+9,492		$0.000000	9,492	31 Jan 2022	Common Stock	9,492		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on February 28, 2022 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.
F2	Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.
F3	The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of January 31, 2023, January 31, 2024, January 31, 2025, and January 31, 2026.